First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal ...

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate.

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Giles Coren, esteemed restaurant critic and writer, has come forward with his prostate cancer diagnosis amid a surge in awareness for the illness. In a week that placed prostate cancer at the top ...

Restaurant critic and journalist Giles Coren has become the latest well-known figure to announce his diagnosis of prostate cancer. It comes in the same week the form of cancer was revealed as the ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

Prostate cancer is a significant health issue in India, with 37,000 new cases and 18,000 deaths annually. AI is ...

Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

YOU MAY HAVE seen people on social media wearing masks or knee wraps that are glowing with bright red light. While they may look like they’ve just stepped out of a sci-fi film, they’re ...